Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.
The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial.
Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease.
HIV resistance testing and detected drug resistance in Europe.
Transmission of HIV drug resistance: lessons from sensitive screening assays.
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.
2014 Update of the drug resistance mutations in HIV-1.
Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.
Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death.
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.